For Business Use Only. Does Not Ship to Residential Addresses. For use inside an Analyzer, Sold Separately.

Thermo Kit EtG Rgt 500mL CJF

https://www.myco-instrumentation.com/web/image/product.template/101263/image_1920?unique=d249266

1,833.90 1833.9 USD 1,833.90

1,833.90

This combination does not exist.

In Stock

Product Code: T-10015893

Manufacturer: Thermo Scientific

Shipping Weight: 2.00lbs (0.91kg)

WHY CHOOSE MYCO INSTRUMENTATION?
See Why in 2 mins.

Thermo Kit EtG Rgt 500mL CJF

Specifications

  • Brand: DRI®
  • Manufacturer: Ortho Clinical Diagnostics
  • Country of Origin: United States
  • Application: Reagent
  • For Use With: For Clinical Chemistry Analyzers
  • Form: Liquid
  • Sample Type: Urine Sample
  • Storage Requirements: Requires Refrigeration
  • Test Name: Ethyl Glucuronide (EtG)
  • Test Type: Drugs of Abuse
  • Volume: 500 mL


Intended Use

The Thermo ScientificTM DRI Ethyl Glucuronide Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of Ethyl Glucuronide in human urine at cutoffs of 500 ng/mL and 1000 ng/mL.


Summary and Explanation of the Test

Ethyl Glucuronide (EtG) is a direct metabolite of ethanol, which is formed by enzymatic conjugation of ethanol with glucuronic acid. Alcohol in urine is normally detected for only a few hours, where as EtG can be detected up to several days even after complete elimination of alcohol from the body. Currently EtG is monitored by GC/MS and LC/MS/MS.

The DRI® Ethyl Glucuronide Assay is supplied as a liquid ready-to-use homogeneous enzyme immunoassay. The assay uses specifi c antibodies that can detect Ethyl Glucuronide without any significant cross-reactivity to other glucuronide compounds. The assay is based on competition between a drug labeled with glucose-6-phosphate dehydrogenase (G6PDH), and free drug from the urine sample for a fi xed amount of specifi c antibody binding sites. In the absence of free drug from the sample, the specifi c antibody binds the drug labeled with G6PDH and causes a decrease in enzyme activity. This phenomenon creates a direct relationship between the drug concentration in urine and enzyme activity. Active enzyme converts NAD to NADH resulting in an absorbance change that can be measured spectrophotometrically at 340 nm.